Timing Protocol

When to Take GLP-1 Agonists — Expert Timing Protocols

Expert-analyzed timing recommendations for glp-1 agonists based on what 5 longevity researchers say about when, how, and what to take it with.

This content is based on expert analysis of publicly available videos, not medical advice. Always consult your healthcare provider before starting, stopping, or changing any supplement.

Quick Timing Guide

Once-weekly injection. No specific time-of-day requirement. Must be combined with strength training and high protein intake (minimum 1g per pound of lean body mass) to mitigate muscle loss (Attia).

2.6/5

Moderate Consensus

on GLP-1 Agonists overall

Full Protocol

Timing

Once-weekly injection. No specific time-of-day requirement. Must be combined with strength training and high protein intake (minimum 1g per pound of lean body mass) to mitigate muscle loss (Attia).

Dosage

Semaglutide: typically starts at 0.25mg/week, titrated up to 2.4mg/week for weight management. Tirzepatide: starts at 2.5mg/week, titrated up to 15mg/week. Dosing is individualized by a prescribing physician (Attia).

Form

Injectable (subcutaneous, once weekly). Oral formulations are in development. Some clinicians use compounded peptide formulations at lower doses (Attia, Koniver).

Notes

This is a prescription medication — not a supplement. Requires physician oversight, regular monitoring via DEXA scans for body composition, and blood work. Compounded versions from reputable pharmacies may offer lower-dose options. High cost remains a significant barrier to access (Attia). Hyman strongly advocates addressing diet and lifestyle first before considering pharmaceutical intervention.

What Each Expert Says About Timing

Andrew Huberman
Andrew Huberman Favorable — Covers Science Extensively

Huberman covers GLP-1 agonists across multiple contexts: hunger neuroscience, peptide therapy, and fat loss protocols. He features Dr. Zachary Knight (UCSF) explaining the mechanism of GLP-1 drugs,...

Peter Attia
Peter Attia Strongly Favorable with Caveats

Attia is the most comprehensive source on GLP-1 agonists, with multiple dedicated episodes spanning mechanism of action, clinical trial analysis, dosing, and evolving perspectives. He provides a de...

Rhonda Patrick
Rhonda Patrick Limited Direct Coverage

Patrick's analyzed videos contain only indirect GLP-1 coverage through a guest appearance by Dr. Ben Bikman, who discusses GLP-1 agonists in the context of insulin resistance reversal. Dr. Bikman a...

Bryan Johnson
Bryan Johnson Limited Direct Coverage

Johnson's analyzed videos contain only tangential GLP-1 coverage. In his podcast with Dr. Mike Israetel, the guest acknowledges that GLP-1 agonists are revolutionizing weight management as anti-obe...

Mark Hyman
Mark Hyman Strongly Opposes Widespread Use

Hyman is the most vocal critic of GLP-1 agonists among all five experts, with multiple dedicated videos arguing against their widespread use. He highlights serious risks including gastroparesis, bo...

Important Notes

This is a prescription medication — not a supplement. Requires physician oversight, regular monitoring via DEXA scans for body composition, and blood work. Compounded versions from reputable pharmacies may offer lower-dose options. High cost remains a significant barrier to access (Attia). Hyman strongly advocates addressing diet and lifestyle first before considering pharmaceutical intervention.

Where Experts Disagree

  • Attia views GLP-1 agonists as powerful, appropriate tools for weight management when combined with exercise and nutrition — while Hyman argues they mask root causes, create lifelong pharmaceutical dependency, and do not address the toxic food environment driving metabolic disease.
  • Attia's position on GLP-1s has evolved significantly over time and he now sees them more favorably, while Hyman has become increasingly critical, particularly regarding their use in children and as a substitute for dietary intervention.
  • On the question of muscle loss: Attia acknowledges it as a serious but manageable risk with proper protein and training protocols, while Hyman and Patrick's guest (Dr. Bikman) frame it as a fundamental problem that undermines the drugs' value.

Timing is half the equation

You know when to take GLP-1 Agonists. Pro shows you what else to take with it, what to avoid, and the full daily schedule across your entire stack — built from 1000+ hours of research data.

  • Full daily timing schedule for your stack
  • Interaction warnings (what cancels out what)
  • Chat about your specific situation with research data
Get Pro — $9/mo

Cancel anytime

Related Timing Guides